Ling Lü
Impact in
- Hepatology top 2%
- Liver physiology and pathology
- Immunology top 2%
- Immune Cell Function and Interaction
- Immune cells in cancer
- T-cell and B-cell Immunology
- interferon and immune responses
Papers in
- Immunology 26
- Immune cells in cancer 9
- Immune Cell Function and Interaction 7
- Co-authors
- Haoming Zhou (17 shared papers)Xuehao Wang (26 shared papers)Jianhua Rao (19 shared papers)Bo Hu (18 shared papers)Hal E. Broxmeyer (2 shared papers)Jiannan Qiu (10 shared papers)Jinren Zhou (10 shared papers)Yuanjin Zhao (6 shared papers)
- Journals
- Annals of Translational Medicine (6 papers)Advanced Science (4 papers)The Journal of Immunology (4 papers)Molecular Biology Reports (3 papers)Oncogene (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Ling Lü
131 papers receiving 3.8k citations
Ling Lü's Hit Papers
Peers
Comparison fields: 5 of 139
- Hepatology 357
- Immunology 899
- Cancer Research 488
- Molecular Biology 1.3k
- Oncology 403
Countries citing papers authored by Ling Lü
This map shows the geographic impact of Ling Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Lü more than expected).
Fields of papers citing papers by Ling Lü
This network shows the impact of papers produced by Ling Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Lü. The network helps show where Ling Lü may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells Hit paper breakdown → | 2022 | 345 |
| 2 | XBP1 deficiency promotes hepatocyte pyroptosis by impairing mitophagy to activate mtDNA-cGAS-STING signaling in macrophages during acute liver injury Hit paper breakdown → | 2022 | 253 |
| 3 | 1993 | 248 | |
| 4 | FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2 Hit paper breakdown → | 2022 | 169 |
| 5 | 2010 | 164 | |
| 6 | 2014 | 118 | |
| 7 | 1991 | 98 | |
| 8 | 2022 | 98 | |
| 9 | 2018 | 95 | |
| 10 | 2008 | 92 | |
| 11 | 2009 | 92 | |
| 12 | 2014 | 71 | |
| 13 | 2014 | 71 | |
| 14 | 2023 | 66 | |
| 15 | 2020 | 63 | |
| 16 | 2019 | 63 | |
| 17 | 2010 | 58 | |
| 18 | 2024 | 55 | |
| 19 | 2009 | 53 | |
| 20 | 2020 | 52 |
About Ling Lü
Ling Lü is a scholar working on Molecular Biology, Immunology, Epidemiology, Hepatology and Surgery, having authored 142 papers that have together received 3.9k indexed citations. Recurring topics across this work include Liver physiology and pathology (10 papers), Liver Disease Diagnosis and Treatment (10 papers), Organ Transplantation Techniques and Outcomes (9 papers), Renal Diseases and Glomerulopathies (9 papers), Immune cells in cancer (9 papers), Autophagy in Disease and Therapy (7 papers), Chronic Kidney Disease and Diabetes (7 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Hepatology (357 citations), Immunology (899 citations), Cancer Research (488 citations), Molecular Biology (1.3k citations) and Oncology (403 citations). Ling Lü has collaborated with scholars based in China, United States and France. Frequent co-authors include Haoming Zhou, Xuehao Wang, Jianhua Rao, Bo Hu, Hal E. Broxmeyer, Jiannan Qiu, Jinren Zhou, Yuanjin Zhao, Stephanie Cooper and Anthony Cerami. Their work appears in journals such as Annals of Translational Medicine, Advanced Science, The Journal of Immunology, Molecular Biology Reports and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.